CUE
Cue Biopharma
NASDAQ: CUE · HEALTHCARE · BIOTECHNOLOGY
$14.74
+13.38% today
Updated 2026-04-30
Market cap
$57.60M
P/E ratio
—
P/S ratio
2.10x
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$5 – $31
Volume
11.4M
Cue Biopharma (CUE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.66M | $-5.97M | $-12.19M | $-26.41M | $-30.80M | $-32.49M | $-38.84M | $-41.81M | $-39.96M | $-36.33M | $-21.69M |
| Capital expenditures | $754287.00 | $515979.00 | $1.20M | $1.85M | $46353.00 | $595259.00 | $913039.00 | $171000.00 | $0.00 | $66000.00 | $177000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $889556.00 | $2.78M | $7.17M | $6.52M | $10.48M | $11.52M | $9.50M | $8.18M | $6.85M | $4.74M |
| Free cash flow | $-2.41M | $-6.48M | $-13.40M | $-28.27M | $-30.84M | $-33.09M | $-39.75M | $-41.98M | $-39.96M | $-36.40M | $-21.86M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $199873.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-42.58M | $23.44M | $30.58M | $-10.50M | $-12.76M | — | — | — |